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ABSTRACT
Objective To compare the effect of evidence based
information on risk with that of standard information on
informed choice in screening for colorectal cancer.
DesignRandomisedcontrolledtrialwith6months’follow-
up.
Setting German statutory health insurance scheme.
Participants 1577 insured people who were members of
the target group for colorectal cancer screening (age 50-
75, no history of colorectal cancer).
Interventions Brochure with evidence based risk
information on colorectal cancer screening and two
optional interactive internet modules on risk and
diagnostictests;officialinformationleafletoftheGerman
colorectal cancer screening programme (control).
Main outcome measure The primary end point was
“informed choice,” comprising “knowledge,”“ attitude,”
and “combination of actual and planned uptake.”
Secondaryoutcomeswere “knowledge”and “combination
of actual and planned uptake.” Knowledge and attitude
were assessed after 6 weeks and combination of actual
and planned uptake of screening after 6 months.
Results The response rate for return of both
questionnaires was 92.4% (n=1457). 345/785 (44.0%)
participants in the intervention group made an informed
choice, compared with 101/792 (12.8%) in the control
group (difference 31.2%, 99% confidence interval 25.7%
to 36.7%; P<0.001). More intervention group participants
had “good knowledge” (59.6% (n=468) v 16.2% (128);
difference 43.5%, 37.8% to 49.1%; P<0.001). A “positive
attitude” towards colorectal screening prevailed in both
groups but was significantly lower in the intervention
group (93.4% (733) v 96.5% (764); difference −3.1%,
−5.9% to −0.3%; P<0.01). The intervention had no effect
onthe combinationof actual andplanned uptake(72.4%
(568) v 72.9% (577); P=0.87).
Conclusions Evidence based risk information on
colorectal cancer screening increased informed choices
and improved knowledge, with little change in attitudes.
The intervention did not affect the combination of actual
and planned uptake of screening.
Trial registration Current Controlled Trials
ISRCTN47105521.
INTRODUCTION
Recommendations on screening for cancer, even if
published by an independent scientific panel, can stir
uppoliticaltempestsandprovokeharshcriticismfrom
influential medical groups.
1 A key factor in the argu-
ment between advocates and critics of screening is the
way in which information about benefit and harm is
communicated.
2 Public campaigns, such as the one
runbythepowerfulFelixBurdaFoundationonscreen-
ing for colorectal cancer in Germany, use persuasive
information.
3 Opponents underscore the ethical
aspects and possible harm of screening, demanding
evidence based information and informed choices.
2
Although policies in Germany and elsewhere increas-
ingly assert that participation in screening should
reflect “informed choice,” this change in approach
has not yet been translated into practice. An unspoken
concern is that understandable, unbiased, and com-
plete information may deter people from participating
in screening. A recent editorial by Bekker in this jour-
nal has shown how common these worries still are,
even among experts and proponents of informed
choice and shared decision making.
4 The article
revived the dispute on the morals and ethics of infor-
mationprocessesincancerscreeningprogrammes,but
the effect of evidence based information on screening
for cancer remains poorly understood.
At the start of this project, we surveyed criteria for
evidence based information for patients and consu-
mers and critically appraised available print and web
based information on screening for colorectal
cancer.
56We did not identify any material, presented
in an unbiased and understandable way, that provided
the information defined by guidelines on ethics.
578
Cancer screening programmes target the healthy
population. Some people will benefit, but more will
have positive test results, receive needless treatment,
or live more years as a patient with cancer. Ethics
guidelines emphasise that evidence based information
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Screening programmes that were implemented well
before that for colorectal cancer have done no better.
In2006JørgensenandGøtzschepublishedasurveyon
the quality of information used in mammography
screening programmes. The major harm of screening
was not mentioned in any of 31 invitations.
9 In 2009
the same authors found that little had changed.
2
Recently, Gigerenzer and colleagues reported a conti-
nuing dramatic overestimation of the possible benefit
of mammography and prostate specific antigen testing
inthevastmajorityofwomenandmen,inallcountries
surveyed.
10 Misconceptions were very pronounced in
regions with screening programmes and when physi-
ciansorpharmacistswereusedasadditionalsourcesof
information. The basis for informed decisions in can-
cer screening is largely non-existent in Europe.
10
We designed this study to compare the effect of evi-
dencebasedinformationonriskofscreeningforcolor-
ectal cancer with that of standard information. We
tested the hypothesis that informed choices would be
higherafterreceiptofevidencebasedriskinformation.
METHODS
We recruited people insured by a large German statu-
tory health insurance scheme, the Gmünder Ersatz-
kasse (GEK), who were members of the target group
forcolorectalcancerscreeninginGermany(age50-75,
no history of colorectal cancer). Considering these
inclusion criteria, we drew a random sample of about
4000 people from the health insurance scheme’s data
pool.InAugust2008thissamplereceivedinformation
and a consent form asking them to participate in a
study that compared two different formats of informa-
tion for patients about screening for colorectal cancer.
This first round did not achieve the calculated sample
size, so we repeated the procedure in November 2008
and again approached about 4000 insured people. We
thus achieved a study group of 1586 people, which
exceeded the planned sample size of 1140. We rando-
mised all who gave informed consent. No further
change to the original study protocol occurred.
Randomisation and blinding
Werandomlyassignedthe1586participantstoreceive
either of the two formats of information on colorectal
cancer screening. We assigned members from the
same household to receive the same information
(n=6). An external person randomised all participants
on 28 December 2008, using a computer generated
sequence of blocks of 10 participants’ identity num-
bers. Allocation was concealed. Identity numbers
were independent of allocation, and study members
did not have access to the data. Trial staff who sent
out questionnaires and reminder letters and entered
data were unaware of the study arm to which partici-
pants had been assigned, as was the statistician. We
excluded nine participants who withdrew informed
consent at the beginning of the study.
Intervention
The evidence based information on risk of colorectal
cancer screening aims to enhance informed decision
making. It is a brochure of 38 pages. Topics cover per-
sonalisedriskofcolorectalcancer,allavailablescreen-
ing options with possible benefit and harm, including
the option not to screen, and prevention of colorectal
cancer. In addition, participants had access to two
interactive internet modules on “risk” and “diagnostic
tests.” These internet modules did not add extra infor-
mationbutofferedtheopportunitytoreadmoreonthe
topic. We did not, therefore, survey use of the internet
modules. In designing and evaluating the information
material,wefollowedtheUKMedicalResearchCoun-
cil’s framework for complex interventions.
11 We com-
piled the information by using the best available
evidence.TheethicsguidelinesoftheGeneralMedical
Council and criteria for evidence based information
guided the selection of information.
57812 This meant,
forexample,thatinformationwaspresentedasnatural
frequencies rather than changes in relative risk, with
comparable reference populations and timeframes.
Weinvolvedmembersofthetargetgroupinthedevel-
opment process from the beginning. We pilot tested
thebrochureinfocusgroupstoassesscomprehensibil-
ity, readability, and acceptability.
1314 In addition, two
leading German gastroenterologists reviewed the
information. Finally, we revised the brochure. We
updated the information in April 2008. During the
studyperiod,thebrochurewasavailableonlytomem-
bers of the intervention group. The brochure and the
interactive modules are now generally accessible on
the internet (brochure: www.gesundheit.uni-ham
burg.de/upload/AltDarmkrebsinternet.pdf; modules:
www.gesundheit.uni-hamburg.de/cgi-bin/newsite/
index.php?page=page_331).
Comparison
The comparison was the official information leaflet of
the German national colorectal cancer screening pro-
gramme.Theinformationwaspublishedin2003andis
still in use.
15 This standard information delineates the
two options for colorectal cancer screening—faecal
occult blood test and colonoscopy. No quantitative
information on individual risk or benefit is included,
and harm is incompletely communicated. The two
tests are part of the national quality assured colorectal
cancer screening programme. Up to now, this screen-
ing programme has not included active invitations or
sending of test kits. People can choose either one of
these tests: from age 50 to 55 years, faecal occult
blood test every year; from age 56, either faecal occult
blood test every two years or colonoscopy every
10 years, up to two colonoscopies.
Procedure
In January 2009 we sent participants either the inter-
vention brochure or the comparison information. At
thesametime,wedrewbaselinedatafromthedatabase
of the health insurance scheme. We assessed
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After six weeks, in February 2009, participants
received a questionnaire to assess “knowledge” and
“attitude,” two dimensions of the primary outcome.
Participants also received a prepaid envelope. Two
reminder letters were sent out, including a new copy
ofthequestionnaire.Sixmonthslater,inJuly2009,we
sent a second questionnaire to assess the combination
of actual and planned uptake of screening. Again, two
reminder letters were sent out.
Outcome measures
The primary outcome measure was “informed
choice,” as described by Marteau et al.
16 We classified
choices about colorectal cancer screening as
“informed” and “uninformed,” according to partici-
pants’ knowledge about screening, their attitudes
towards screening, and whether they had colorectal
cancer screening.
16 We classified participants with
goodknowledgeandpositiveattitudewhohadscreen-
ing as making an informed choice. We also classified
participants with good knowledge and a negative atti-
tude who did not have screening as making an
informed choice.
We translated and re-translated the instrument
developed by Marteau et al. We adapted the knowl-
edge questionnaire to screening for colorectal cancer.
We pilot tested the questionnaire in a separate sample
of 62 people in the target group for colorectal cancer
screening, using the same inclusion criteria as in the
main trial. We did 22 interviews, applying the “think
aloud” method. After revision, questionnaires were
sent out with the evidence based risk information
(n=20) and the standard information (n=20). This eva-
luation step did not result in further revision of the
questionnaire.
We coded questionnaires according to a predefined
coding sheet.
16 Each correct response scored one
point, leading to a maximum score of eight points.
We counted missing responses as wrong answers. We
rated participants as having good knowledge if they
had a score of at least 4. We deemed participants to
have a positive attitude if they had a score below 2.5
(maximum score 4). We assessed the combination of
actual and planned uptake by two questions. As the
timeframes in the colorectal cancer screening pro-
gramme in Germany would exceed any study period
(10 years for colonoscopy screening and one to two
years for occult blood test, depending on age), uptake
comprised the combination of actual and planned
uptake. As knowledge is a prerequisite to achieve the
category “informed choice,” we decided to analyse
knowledge as a secondary outcome. In addition, we
defined “combination of actual and planned uptake”
as a secondary outcome.
Wehaddecidednottoassesscomponentsoftheout-
comemeasuresatbaselineformethodologicalreasons.
Applying the same questionnaires twice within six
weeks would have biased results.
Statistical analysis
Forthe samplesizecalculation,we assumedthatabout
10%ofthetargetgroupwouldmakeaninformeddeci-
sion when using standard information. We considered
anincreaseof10%ofparticipantsmakinganinformed
decision to be an important improvement. Aiming for
a power of 90% at an α error of 1%, we therefore
needed 397 participants in each study group. Taking
into account a non-responderrate of 30% would result
in a sample size of at least 1140 participants.
We did the primary analysis according to intention
to treat, using the full analysis set. The variables con-
sideringknowledgedidnotcontainanymissingvalues
because we counted only correct answers as knowl-
edge. We imputed missing values individually in the
binomial outcomes of attitude (positive/negative) and
combination of actual and planned uptake (yes/no) in
the following manner. We imputed missing values in
some items of attitude by using auxiliary variables of
similar content. We imputed the remaining missing
valuesinthedichotomousvariableattitudebyrandom
numbersfromabinomialdistributionbyusingtheesti-
mated probability on the subpopulation without miss-
ing values. In the same manner, we imputed missing
values of the variable “combination of actual and
planned uptake” by using binomially distributed ran-
dom numbers. We calculated the primary outcome of
informed choice from the variables “good knowl-
edge,”“ positive/negative attitude,” and “combination
of actual and planned uptake yes/no” after imputation
of missing values. In total, we imputed 219 missing
values into informed choice. Additionally, we did a
per protocol analysis excluding participants with any
missing values for the main outcome.
We present baseline variables as means and stan-
dard deviation or frequency distributions. We ana-
lysed the primary outcome by comparing the
probabilities of informed choice between the inter-
vention and control group by Fisher’s exact test with
a two sided significance level of 1%. We estimated the
difference of the probabilities and a 99% confidence
interval. We analysed the secondary outcomes good
knowledge, positive attitude, and combination of
actual and planned uptake in the same manner.
We also analysed knowledge and attitude scores as
continuous variables and presented them as means
(SD). We used Wilcoxon’s rank sum test to compare
groups, excluding participants with missing values. In
theseadditionalanalyses,theconfidencelevelwas5%.
All tests were two sided. We used SAS version 9.2 for
statistical calculations.
In January2011we didadditionalpost-hocanalyses
ofhealthinsurancedataonuptakeofscreeningforcol-
orectal cancer on the basis of physicians’ claims. We
provide information on faecal occult blood test and
colonoscopy as documented for the three years before
the study and for the six months after the intervention,
using the same methods as above.
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The baseline characteristics of eligible insured people
who agreed to participate in this study on the compar-
ison of different screening information formats
(n=1577) were comparable in terms of sex and age to
thoseof peoplewhodeclined(n=6369): women42.7%
(673/1577) versus 43.3% (2760/6369); mean age 61.2
(SD7.0)versus60.7(7.3).However,accordingtoinsur-
anceschemedata,peoplewhodeclinedwerelesslikely
to have a documented screening occult blood test
(48.1% (759/1577) v 36.1% (2297/6369)) or screening
colonoscopy (13.6% (215/1577) v 6.8% (434/6369))
during the three year pre-study period. We analysed
informed choice for 1577 of 1586 randomised partici-
pants (figure).
Overall, 1457 (92.4%) participants returned both
questionnaires; 48 (3.0%) did not return any question-
naire. The remaining 72 (4.6%) participants returned
one of the questionnaires. Baseline characteristics of
the two groups were comparable (table 1).
Recipients of evidence based risk information were
muchmorelikelytomakeinformedchoicesthanwere
recipients of standard information (44.0% (345/785) v
12.8% (101/792); difference 31.2%, 99% confidence
interval 25.7% to 36.7%; P<0.001). Table 2 sum-
marises the analyses of the single dimensions of the
primary outcome. Significantly more participants in
the intervention group than in the control group had
good knowledge (59.6% (468/785) v 16.2% (128/792);
difference 43.5%, 37.8% to 49.1%; P<0.001). The
mean knowledge score (score 0-8) in the intervention
group was 4.3 (SD 2.3) compared with 2.5 (1.2) in the
control group (P<0.001). Table 3 shows the results for
the multiple choice items assessing knowledge. Posi-
tive attitude was significantly lower in the intervention
group than in the control group (93.4% (733/785) v
Allocated to receive standard information
  (n=792)
Received allocated intervention (n=792)
Allocated to receive evidence based information
  (n=785)
Received allocated intervention (n=785)
Assessed for eligibility (n=7946)
Randomised (n=1577)*
First questionnaire sent after 6 weeks to survey
  “knowledge” and “attitude” 
Second questionnaire sent after 6 months to
  survey “uptake”
First questionnaire sent after 6 weeks to survey
  “knowledge” and “attitude” 
Second questionnaire sent after 6 months to
  survey “uptake”
Participants returned both
questionnaires for analysis (n=737)
Participants returned both
questionnaires for analysis (n=720)
Declined to participate (n=6369)
First questionnaire not returned (n=48)
Second questionnaire not returned (n=47)
First questionnaire not returned (n=34)
Second questionnaire not returned (n=39)
Flow of participants through trial. *At start of study 9/1586 randomised participants withdrew
informed consent and were therefore excluded
Table 1 |Baseline characteristics of participants. Values are numbers (percentages) unless stated otherwise
Characteristic Evidence based risk information (n=785) Standard information (n=792)
Female sex 349 (44.5) 324 (40.9)
Mean (SD) age (years) 60.8 (6.9) 61.5 (7)
Age group (years):
50-59 377 (48.0) 351 (44.3)
60-69 297 (37.8) 308 (38.9)
70-79 111 (14.1) 133 (16.8)
Education: (n=703) (n=733)
No qualification 2 (0.3) 3 (0.4)
Secondary school 9 years 345 (49.1) 402 (54.8)
Secondary school 10 years 242 (34.4) 218 (29.7)
General Certificate of Education A Level 114 (16.2) 110 (15.0)
First language German 712/732 (97.3) 724/744 (97.3)
Occupational status: (n=693) (n=714)
Untrained 25 (3.6) 39 (5.5)
Vocational training 595 (85.9) 603 (84.5)
University graduate 73 (10.5) 72 (10.1)
Employed 348/738 (47.2) 317/753 (42.1)
Household income: (n=671) (n=690)
<500-1500 € 140 (20.9) 147 (21.3)
1500-3000 € 389 (58.0) 419 (60.7)
3000->5000 € 142 (21.2) 124 (18.0)
Screening during 3 years before study:
Occult blood test 376 (47.9) 383 (48.4)
Colonoscopy 105 (13.4) 110 (13.9)
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P<0.01). The mean attitude score was 1.4 (0.6) in the
intervention group and 1.3 (0.5) in the control group
(P<0.001) (missing values 93 v 88). The difference in
self reported combination of actual and planned
uptake was not statistically significant (72.4% (568/
785) v 72.9% (577/792); difference −0.5%, −6.3 to
5.3; P=0.87). Per protocol analysis did not affect these
findings (data not shown). Missing values thus seem
unlikely to have affected our conclusions.
Health insurance data on actual uptake support the
lack of difference in the combination of actual and
planneduptakeuptosixmonthsaftertheintervention.
A screening faecal occult blood test was documented
for 18.0% (141/785) of the intervention group com-
pared with 16.9% (134/792) of the control group (dif-
ference 1%, −3.9% to 6.0%; P=0.60), and screening
colonoscopy was documented for 3.8% (30/785) ver-
sus 3.4% (27/792) (difference 0.4%, −2.0 to 2.8%;
P=0.69).
DISCUSSION
An evidence based brochure on screening for colorec-
tal cancer significantly increased the proportion of
participants who made informed choices. Uptake of
screening for colorectal cancer was not affected. Posi-
tive attitudes were predominant in both the inter-
vention and control groups.
Strengths and limitations of study
The evidence based risk information studied in this
trial has been developed and evaluated according to
the UK Medical Research Council’s framework for
complex interventions.
11 In phase 1, we systematically
analysed the available information material on screen-
ingforcolorectalcancer,surveyedthepreferencesand
information needs of the target group, processed the
content according to the standards of evidence based
medicine, and modelled the intervention.
5613In phase
2,we pilottested the firstdraftforreadability,compre-
hensibility, completeness, and acceptance, and we
commissioned two expert reviews.
131417 Phase 3 com-
prises the evaluation in a randomised controlled trial
presented here.
11
The trial design was rigorous for several reasons.
Blinding of randomisation, study participants, assess-
ment of outcome measures, and analyses minimised
bias. Attrition rates were very low, and the primary
Table 3 |Multiple choice items of knowledge questionnaire (possible answers in parentheses). Values are numbers (percentages) with correct answers
Item of knowledge
Evidence based information
(n=785)
Standard information
(n=792)
1. Which disease is the occult blood test (for example, Haemoccult) supposed to detect? (irritable bowel syndrome,
inflammatory bowel disease, colorectal cancer*, haemorrhoids)
632 (80.5) 623 (78.7)
2. When can an occult blood test lead to a false positive test result? If on the day before the test (one consumed raw
meat*, one consumed fish, one drunk alcohol, one smoked cigarettes)
655 (83.4) 632 (79.8)
3. Imagine 1000 people in your age group who have positive test results in their occult blood test. How many out of these
1000 people really have colorectal cancer?† (1000, 980, 700, 400* (age 60-79), 100* (age 50-59), 10)
369 (47.0) 177 (22.3)
4. The risk for colorectal cancer increases with age. How high do you estimate the risk for colorectal cancer to be in your
age group during the next 10 years?† (1 in 761, 1 in 237* (age 50-59), 1 in 92* (age 60-69), 1 in 38* (age 70-79), 1 in 18)
392 (49.9) 207 (26.1)
5. Screening with the occult blood test decreases the risk of dying from colorectal cancer. Imagine 1000 people start from
age 50 to regularly participate in the screening programme. How many fewer people do you estimate would die from
colorectal cancer? (1-2*, 8-10, 50-100, 200-400, 800-990)
305 (38.9) 29 (3.7)
6. For colorectal cancer screening, either the occult blood test or colonoscopy may be used. It is important that studies
are available that have investigated the benefit and harm of these medical tests. Please rate whether such studies are
available for these tests. (“yes*/no” for occult blood test; “yes/no*” for colonoscopy)
194 (24.7) 52 (6.6)
7. Imagine 1000 people in your age group who have negative test results in their occult blood test. Please rate how many
out of these 1000 people really do not have colorectal cancer† (1000, 999* (age 50-59), 990* (age 60-79), 850, 400,
100, 10)
376 (47.9) 152 (19.2)
8. Colonoscopy may be associated with severe side effects. Please rate what side effects may occur with colonoscopy.
Please mark all correct answers. (faecal incontinence, bleeding*, bowel occlusion, bowel perforation*, death*)
437 (55.7) 103 (13.0)
*Correct answer.
†Items analysed according to age of participants.
Table 2 |Primary outcome (informed choice) at six months’ follow-up and dimensions of informed choice: knowledge, attitude, and uptake. Values are
numbers (percentages) unless stated otherwise
Outcome Evidence based information (n=785) Standard information (n=792) % difference (99% CI); P value
Informed choice 345 (44.0) 101 (12.8) 31.2 (25.7 to 36.7); <0.001
Good knowledge* 468 (59.6) 128 (16.2) 43.5 (37.8 to 49.1); <0.001
Positive attitude* 733 (93.4) 764 (96.5) −3.1 (−5.9 to −0.3); <0.01
Uptake of colorectal cancer screening† 568 (72.4) 577 (72.9) −0.5 (−6.3 to 5.3); 0.87
*After six weeks.
†Combination of actual and planned uptake after six months.
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background of the study participants was, if anything,
belowtheaverageoftheGermanpopulation,
18andwe
had a predominance of men corresponding to the
structure of people insured by the cooperating statu-
tory health insurance scheme as well as the risk distri-
bution of colorectal cancer.
Thetrialalsohaslimitations.Studyparticipantswere
more likely to take part in colorectal cancer screening
than were insured people who showed no interest in
participating in this investigation on the effects of two
different formats of information on screening. How-
ever, these findings are unlikely to have affected the
primary outcome of informed choice. We also do not
expect relevant differential effects on the secondary
outcomesofcombinationofactualandplanneduptake
andattitude.Asweshowedinaformerstudyofcitizens
of Hamburg, even recruitment strategies that did not
disclose any relation to health topics led to samples
extremely in favour of cancer screening.
14 Because of
screeningintervalsoftwoyearsforoccultbloodtesting
and 10 years for colonoscopy, we rated uptake as the
combination of actual and planned uptake of screen-
ing. In Germany, claims data from health insurance
schemes are not available until about nine months
after the event. However, post hoc analyses of health
insurance data support the lack of effects on actual
uptake.Inaddition,alldata arelimitedbytheimpreci-
sion inherent to questionnaire surveys. Finally, we
were not able to evaluate possible adverse effects.
Meaning of results
Our results support and extend the findings of other
trials. A recently updated literature search identified
somenewpublicationsonrelatedtopics.Foxidentified
nine studies on information material used in screening
programmes.
19 Whereas five out of eight trials asses-
sing knowledge showed increased knowledge, only
one of those assessing attitude showed any change in
attitude towards a more negative screening attitude.
19
In contrast, Krist et al found that a decision aid
enhancedknowledgeanddecreaseduptakeinprostate
cancer screening.
20
Our study adds important new knowledge, as the
outcome measure of informed choice has scarcely
been studied. None of the trials included in the review
of Fox assessed this outcome.
19 Mathieu et al studied
the effect on informed choices of a decision aid on
mammographyfor70yearoldwomen.
21Thedecision
aid significantly increased informed choices and also
knowledge; uptake was not affected.
21 A recently pub-
lished trial by Trevena et al also found that a decision
aid on screening for colorectal cancer increased
informed choices without affecting uptake.
22 Marteau
et al assessed the effect of an evidence based invitation
on screening for diabetes.
23 The intervention did not
reduce uptake of screening.
23 The lack of effect of
improvedknowledgeaboutriskonuptakeofscreening
in our study may be due to the overall high level of
positive attitudes towards cancer screening in
Germany and rejection of risk information for reasons
of cognitive dissonance.
14
Whilethismanuscriptwasgoingthroughthe review
process, Smith et al published their evaluation of a
decision aid on occult blood screening in adults with
low education in the Australian screening
programme.
24 Test kits were posted to both study
groups. The authors assessed the primary outcomes
“informed choice” and “preferences for involvement
in the screening decision” in a telephone interview
two weeks after the intervention. The decision aid sig-
nificantly increased informed choice and knowledge
and also reduced the participation rate compared
with standard information.
24 The accompanying edi-
torial raised concerns that uncritical acceptance of
initiatives to promote informed choice may cause
more harm than good; it may rather facilitate adher-
encetotesting,onceefficacyhasbeenshowntoreduce
mortality.
4 The editorial elicited a dispute on ethics in
screeningprogrammesandtherolesofshareddecision
making and patients’ autonomy.
2526
In contrast, the German screening programme
includes neither active invitations nor the posting of
test kits. Therefore, the fact that a high number of
insured people who were asked to take part in our
study on different formats of screening information
showed no interest in participating was not unex-
pected. As Dalton pointed out, health screening is ele-
vated to a moral good for public health practitioners,
whereas for the autonomous other (patient) it is just a
lifestyle choice.
25
Implications for policy makers and clinicians
In a healthcare system, providing quality assurance
and the opportunity to access evidence based health
information would be expected to increase informed
choicewithoutchanginguptakeofscreeningforcolor-
ectal cancer. Our results support the ethics guidelines’
demand for evidence based, reliable, and easy to
understand information on the benefit and harm of
screeninginterventions.Suchinformationhastotarget
informed choices. Campaigns using misleading pre-
sentations of information are delusive and should be
abandoned.
Remarkably, the evidence based risk information
used here achieved a relevant increase in informed
choices without additional interventions. Counselling
was not provided. The brochure may now be down-
loaded from the internet (brochure: www.gesundheit.
uni-hamburg.de/upload/AltDarmkrebsinternet.pdf;
modules: www.gesundheit.uni-hamburg.de/cgi-bin/
newsite/index.php?page=page_331). Meanwhile, the
criteria for evidence based information on cancer
screening which had been applied to the tested infor-
mationhavebeendefinedasastandardbytheGerman
Network for Evidence Based Medicine.
27
People and organisations designing and implement-
ing screening programmes should respect the ethical
right of consumers for evidence based information
and informed choices.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Informationforpatientsoncancerscreeningisoftenbiased,
incomplete, and persuasive
Guidelines on ethics promote evidence based information
and informed choices
The effects of evidence based information in cancer
screening are incompletely understood
WHAT THIS STUDY ADDS
When standard information is used, very few people make
an informed choice on screening for colorectal cancer
A simple evidence based brochure without additional
counselling may substantially increase informed choices
Increasingknowledgeofriskhadlittleeffectonattitudeand
no effect on uptake of screening within six months
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